Company:  APTOSE BIOSCIENCES INC. (APTO)
Form Type:  4
Filing Date:  3/14/2019 
CIK:  0000882361 
Address:  251 CONSUMERS ROAD
SUITE 1105
 
City, State, Zip:  TORONTO,  M2J 4R3 
Telephone:  647-479-9828 
Fiscal Year:  12/31 
Last Trade
Last Trade: 
$2.31  
Change: 
0.13 (5.96%)  
Trade Time: 
02:50 PM EST  
Market Cap: 
$95.86M
Trade APTO now with

© 2019  
Description of Business
Aptose is a science-driven biotechnology company advancing highly differentiated agents to treat unmet medical needs in life-threatening cancers, such as acute myeloid leukemia ("AML"), certain B-cell malignancies, high-risk myelodysplastic syndromes ("MDS") and other hematologic malignancies. Aptose is a publicly listed company incorporated under the laws of Canada. The Company's shares are listed on the Nasdaq Capital Markets and the Toronto Stock Exchange. The Company was incorporated on September 5, 1986 under the name RML Medical Laboratories ("RML") pursuant to the Business Corporations Act (Ontario). Between 1986 and 2014, the Company operated under the names of RML, IMUTEC Corporation and Lorus Therapeutics Inc. On August 28, 2014, the Company changed its name from Lorus Therapeutics Inc. to Aptose Biosciences Inc.
Register and access this filing in:     
  FORM 4
    NAME AND TITLE
    NON DERIVATIVE SECURITIES
    DERIVATIVE SECURITIES
    EXPLANATIONS AND REMARKS
    REPORTING OWNERS
    SIGNATURES